No Data
No Data
Apollomics Inc Trading Halted, Volatility Trading Pause
Express News | Apollomics Shares Are Trading Lower. The Company Reported FY24 Financial Results
20-F: FY2024 Annual Report
6-K: Report of foreign private issuer (related to financial reporting)
Apollomics FY24 Loss/Shr $52.80 >APLM
Apollomics Signs Exclusive Development, Commercialization Deal for Vebreltinib in Asia